Q&A With Sullivan & Cromwell's Matthew Hurd

Law360, New York (July 16, 2012, 1:58 PM EDT) -- Matthew Hurd is a partner in Sullivan & Cromwell LLP's New York office. As co-head of the firm’s health care and life sciences practice with nearly 20 years focused on its development, he advises domestic and international clients on mergers and acquisitions and complex investment transactions in pharmaceuticals, biotechnology, medical devices, and health care insurance and benefits. In 2011, he acted for Medco Health Solutions Inc. in its $34.3 billion acquisition by Express Scripts Inc., and Pharmasset Inc. in its $11 billion acquisition by Gilead Sciences...
To view the full article, register now.